Recurrence-free survival in ER-positive patients with different genotypes of and tamoxifen randomisation

<p><b>Copyright information:</b></p><p>Taken from "Genetic variants of , , , and tamoxifen response in postmenopausal patients with breast cancer"</p><p>Breast Cancer Research 2007;9(1):R7-R7.</p><p>Published online 23 Jan 2007</p><p>PMCID:PMC1851378.</p><p></p> The solid line represents patients homozygous for the allele, and the dotted line represents patients homozygous or heterozygous for the allele. and 2 years of tamoxifen therapy; and 5 years of tamoxifen therapy